SI9300349A - Substitunirani piridinil-2 propeonati in njihovi homologi - Google Patents
Substitunirani piridinil-2 propeonati in njihovi homologi Download PDFInfo
- Publication number
- SI9300349A SI9300349A SI9300349A SI9300349A SI9300349A SI 9300349 A SI9300349 A SI 9300349A SI 9300349 A SI9300349 A SI 9300349A SI 9300349 A SI9300349 A SI 9300349A SI 9300349 A SI9300349 A SI 9300349A
- Authority
- SI
- Slovenia
- Prior art keywords
- methyl
- pyridinyl
- dichlorophenylthio
- sodium
- propenoate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90677192A | 1992-06-30 | 1992-06-30 | |
| US2519893A | 1993-03-02 | 1993-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300349A true SI9300349A (sl) | 1993-12-31 |
Family
ID=26699422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9300349A SI9300349A (sl) | 1992-06-30 | 1993-06-30 | Substitunirani piridinil-2 propeonati in njihovi homologi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5990314A (ko) |
| EP (1) | EP0649412B1 (ko) |
| JP (1) | JP3230682B2 (ko) |
| KR (1) | KR950702185A (ko) |
| CN (1) | CN1108247A (ko) |
| AT (1) | ATE231129T1 (ko) |
| AU (2) | AU4545893A (ko) |
| CA (1) | CA2138954A1 (ko) |
| DE (1) | DE69332640T2 (ko) |
| ES (1) | ES2191014T3 (ko) |
| IL (1) | IL106156A0 (ko) |
| MA (1) | MA22926A1 (ko) |
| MX (1) | MX9303973A (ko) |
| NZ (1) | NZ253967A (ko) |
| SI (1) | SI9300349A (ko) |
| WO (1) | WO1994000437A1 (ko) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0711282B1 (en) | 1993-07-28 | 2002-06-05 | Aventis Pharma Limited | Compounds as pde iv and tnf inhibitors |
| EP0733044A4 (en) * | 1993-12-08 | 1997-03-05 | Smithkline Beecham Corp | CHEMICAL COMPOUNDS |
| JPH09506366A (ja) * | 1993-12-09 | 1997-06-24 | スミスクライン・ビーチャム・コーポレイション | ロイコトリエンｂ▲下４▼に関連する疾患を治療するのに有用なジフェニル−２−プロペノエートおよびその同族体 |
| DE69609820T2 (de) * | 1995-03-02 | 2001-03-08 | Smithkline Beecham Corp | Verwendung von substituirten Pyridinverbindungen zur Behandlung der atopischen Dermatitis und der Kontaktdermatitis |
| GB9508137D0 (en) * | 1995-04-21 | 1995-06-07 | Smithkline Beecham Plc | Formulation |
| GB9602675D0 (en) * | 1996-02-09 | 1996-04-10 | Smithkline Beecham Plc | Process |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| JP2001501202A (ja) * | 1996-09-26 | 2001-01-30 | ノバルティス アクチエンゲゼルシャフト | ロイコトリエンｂ４（ｌｔｂ―４）レセプターアンタゴニスト活性によるアリル置換アクリルアミド |
| US7361671B2 (en) * | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07116150B2 (ja) * | 1990-06-07 | 1995-12-13 | スミスクライン・ビーチャム・コーポレイション | 安息香酸誘導体 |
| KR930700445A (ko) * | 1990-06-07 | 1993-03-15 | 원본미기재 | 로이코트리엔-관련 질병치료용 벤조산 유도체 |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
-
1993
- 1993-06-28 IL IL106156A patent/IL106156A0/xx unknown
- 1993-06-28 MA MA23216A patent/MA22926A1/fr unknown
- 1993-06-30 MX MX9303973A patent/MX9303973A/es unknown
- 1993-06-30 EP EP93915498A patent/EP0649412B1/en not_active Expired - Lifetime
- 1993-06-30 SI SI9300349A patent/SI9300349A/sl unknown
- 1993-06-30 CN CN93109519A patent/CN1108247A/zh active Pending
- 1993-06-30 DE DE69332640T patent/DE69332640T2/de not_active Expired - Fee Related
- 1993-06-30 JP JP50265894A patent/JP3230682B2/ja not_active Expired - Fee Related
- 1993-06-30 NZ NZ253967A patent/NZ253967A/en unknown
- 1993-06-30 ES ES93915498T patent/ES2191014T3/es not_active Expired - Lifetime
- 1993-06-30 CA CA002138954A patent/CA2138954A1/en not_active Abandoned
- 1993-06-30 WO PCT/US1993/006234 patent/WO1994000437A1/en active IP Right Grant
- 1993-06-30 AT AT93915498T patent/ATE231129T1/de not_active IP Right Cessation
- 1993-06-30 AU AU45458/93A patent/AU4545893A/en not_active Abandoned
-
1994
- 1994-12-05 US US08/656,169 patent/US5990314A/en not_active Expired - Lifetime
- 1994-12-29 KR KR1019940704801A patent/KR950702185A/ko not_active Application Discontinuation
-
1997
- 1997-05-13 AU AU22807/97A patent/AU707102B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US5990314A (en) | 1999-11-23 |
| NZ253967A (en) | 1996-11-26 |
| AU4545893A (en) | 1994-01-24 |
| AU707102B2 (en) | 1999-07-01 |
| CN1108247A (zh) | 1995-09-13 |
| DE69332640T2 (de) | 2003-11-06 |
| KR950702185A (ko) | 1995-06-19 |
| AU2280797A (en) | 1997-08-14 |
| ES2191014T3 (es) | 2003-09-01 |
| EP0649412B1 (en) | 2003-01-15 |
| CA2138954A1 (en) | 1994-01-06 |
| EP0649412A1 (en) | 1995-04-26 |
| IL106156A0 (en) | 1993-10-20 |
| MX9303973A (es) | 1994-04-29 |
| JP3230682B2 (ja) | 2001-11-19 |
| WO1994000437A1 (en) | 1994-01-06 |
| ATE231129T1 (de) | 2003-02-15 |
| MA22926A1 (fr) | 1994-04-01 |
| JPH07508284A (ja) | 1995-09-14 |
| DE69332640D1 (de) | 2003-02-20 |
| EP0649412A4 (en) | 1995-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6023846B2 (ja) | ホスホジエステラーゼ阻害剤としての１−フェニル−２−ピリジニルアルキルアルコールの誘導体 | |
| AP333A (en) | Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases. | |
| SI9300349A (sl) | Substitunirani piridinil-2 propeonati in njihovi homologi | |
| US5643914A (en) | Pharmaceutical pyridine compounds | |
| KR20010085852A (ko) | 2,3-이치환 피리딘 유도체, 그의 제조방법, 그를 함유하는의약 조성물, 및 그의 제조용 중간체 | |
| WO1994014797A1 (en) | Quinoline compounds and the treatment of leucotriene related diseases therewith | |
| US5569677A (en) | Diphenyl-2-propenoates for treating diseases associated with leukotriene B4 | |
| EP0812194B1 (en) | Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis | |
| US5656636A (en) | Pyridine compounds for treating leukotriene-related diseases | |
| EP0732919A1 (en) | Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 | |
| EP0733044A1 (en) | Compounds | |
| US5929096A (en) | Method for treating atopic dermatitis and contact dermatitis | |
| EP0548291A1 (en) | Pyridylthio or pyridyloxy alkanoic acids | |
| EP0267439A2 (en) | Alpha-(phenylalkyl) pyridinealkanol derivatives | |
| WO1991018883A1 (en) | Amide linked pyridyle-benzoic acid derivatives for treating leukotriene-related diseases | |
| JPS63174949A (ja) | 新規カルボン酸誘導体、その製法、およびこれを含有する物質代謝疾患療用薬剤 | |
| EP0639975A1 (en) | Heterocyclic-substituted pyridine compounds and uses | |
| WO1993011768A1 (en) | Pyridyl compounds for psoriasis treatment | |
| JPH08505148A (ja) | ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物 | |
| SI9200314A (sl) | Spojine za zdravuanje bolezni, ki so v zvezi z levkotrieni | |
| WO1993022285A1 (en) | Leukotriene antagonists | |
| JP2005519951A (ja) | β３アドレナリン性受容体作動薬としてのアミノアルコール誘導体 |